Menu
Back to Journals » OncoTargets and Therapy » Volume 9
Review
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,238 | Dovepress* | 10,418+ | 1,589 | 12,007 | |
| PubMed Central* | 4,820 | 1,102 | 5,922 | ||
| Totals | 15,238 | 2,691 | 17,929 | ||
| *Since 20 October 2016 | |||||
View citations on PubMed Central and Google Scholar